25 Stocks Jim Cramer Recently Shared Insights On

Page 19 of 24

6. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 69

Bristol-Myers Squibb Company (NYSE:BMY) is one of the 25 stocks Jim Cramer recently shared insights on. While discussing drug stocks, Cramer mentioned BMY and said:

“Of course, some of the rally’s nothing more than the left-behind stocks playing catch up. The drug stocks had a rare day in the sun. I wish I had something good to say about them. Maybe it’s enough to say that Bristol Myers has a faint pulse, one that lasted until the end of the session.”

Bristol-Myers Squibb (NYSE:BMY) develops and markets biopharmaceutical products across areas like oncology, immunology, cardiovascular, and neuroscience. The company provides a diverse portfolio of therapies for cancer, autoimmune diseases, and chronic conditions. During an early June episode, Cramer showed disappointment in the company stock, as he said:

“Bristol Myers, Charitable Trust owns it. So far, we’re not happy with COBENFY. It’s a little disappointing. We need to see that stock back up at 60.”

Page 19 of 24